Product Information

LEVETIRACETAM 250 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0568 per EA under NDC 50228047005. Its NADAC has been published 205 times since Dec 14, 2022.

FDA first approved this application on Jun 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM 250 MG TABLET

Levetiracetam
$0.0568per EA

Strength

250 mg/1

NDC

50228047005

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA215069

FDA Approved

6/11/2021

TE Code

AB

On Market Since

5/27/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM 250 MG TABLET has been published 205 times since Dec 14, 2022, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0568 per EA
All-time high$0.0740 (Dec 13, 2023)
All-time low$0.0454 (Nov 20, 2024)
52-week high$0.0605
52-week low$0.0562
Median price$0.0612
Average price$0.0614
Largest weekly change+30.7% (Aug 21, 2024)
Weeks tracked205
Tracking sinceDec 14, 2022

Price History

1W

0.0%

1M

+1.1%

3M

-3.6%

6M

-2.5%

1Y

-4.2%

3Y

-16.5%

5Y

N/A

All

-20.4%

Generic Alternatives

The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0568 per EA (NDC 50228047005), effective Nov 11, 2026.

How has the price of LEVETIRACETAM 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 20.4%. It has been tracked across 205 weekly CMS publications since Dec 14, 2022.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?

Since Dec 14, 2022, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0740 (Dec 13, 2023), with a median of $0.0612 per EA.

Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?

Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 13% below LEVETIRACETAM 250 MG TABLET.

Who manufactures LEVETIRACETAM 250 MG TABLET?

LEVETIRACETAM 250 MG TABLET (NDC 50228047005) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.